Company intelligence / Profile preview
Bioheart, Inc.
Sunrise, Florida, United Statesusstemcell.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Bioheart has developed autologous cell therapies such as MyoCell and MyoCell SDF‑1 for chronic heart failure. These therapies aim to improve cardiac function by repopulating scarred regions of the heart with gene-modified muscle cells that secrete additional SDF‑1 protein. Clinical trial results have been presented at major conferences; however, the company has faced financial challenges and regulatory hurdles.[7][8]
Adipocell is a kit-based product using autologous adipose-derived stem cells for various potential applications.[8]
Revenue has declined significantly over recent years as per public filings.[8]
The company was renamed U.S. Stem Cell, Inc., but its legacy programs are still often referred to under the Bioheart name.
There are also unrelated companies named "Bioheart" in China focused on cardiovascular devices rather than cellular therapy; this profile focuses on the US-based biotech entity.- Therapeutic areas
- Cardiovascular
- Modalities
- Autologous cell therapies (muscle cells/myoblasts, adipose-derived cells)Gene-modified cell therapy (adenovirus vector for SDF-1 expression)
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
None specifically disclosed in recent filings or news.
Beyond the preview
Go deeper on Bioheart, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bioheart, Inc..